It is worth highlighting the interesting tradeoff noted above: Loss of Msh3 may protect against expansions but, on the other hand, can result in MMR deficiencies, as seen in human cancers (Adam et al. 2016). The gene discussed is MSH3; the disease is hyperinsulinemic hypoglycemia, familial, 4.